Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 Study of LY2523355 (litronesib) in Patients with Solid Cancer
jRCT2080221457Phase 1
- Sponsor
- Kyowa Kirin
- Start
- May 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of litronesib in Nonhematologic neoplasms, sponsored by Kyowa Kirin.
02
Drugs
litronesib
03
Conditions
Nonhematologic neoplasms
Beyond the preview
Go deeper on jRCT2080221457.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080221457.